Innate Pharma S.A. earnings per share and revenue

IPHA earnings per share for the last semiannual are -0.13 USD whereas the estimation was -0.44 USD which accounts for 70.14% surprise. Företagets omsättning för samma period uppgår till 23.24 M USD trots den uppskattade siffran 18.15 M USD. Estimated earnings per share for the next semiannual are -0.36 USD, and revenue is expected to reach 11.05 M USD. Also watch annual changes over time to get a bigger picture of IPHA earnings per share and revenue dynamics.